Literature DB >> 6400195

Biodegradable polymers in controlled drug delivery.

J Heller.   

Abstract

Erosion mechanisms are divided into three types and drug release within each type is described. Type I erosion involves hydrolysis of hydrogels and these are useful in the controlled release of macromolecules entangled within their network structure. Type II erosion involves solubilization of water-insoluble polymers by reactions involving groups pendant from the polymer backbone. Of particular interest are polymers that solubilize by ionization of carboxylic acid groups, and the utilization of those systems is described. Type III erosion involves cleavage of hydrolytically labile bonds within the polymer backbone and four distinct polymer systems within this category are under development. One system involves the diffusion of drugs from a reservoir through a bioerodible membrane, another system utilizes microcapsules, a third system utilizes monolithic devices, and the fourth system utilizes drugs chemically bound to a bioerodible polymer.

Entities:  

Keywords:  Biodegradable Delivery Systems; Contraception; Contraceptive Methods; Economic Factors; Family Planning; Ingredients And Chemicals; Literature Review; Polymers; Research And Development; Technology

Mesh:

Substances:

Year:  1984        PMID: 6400195

Source DB:  PubMed          Journal:  Crit Rev Ther Drug Carrier Syst        ISSN: 0743-4863            Impact factor:   4.889


  13 in total

Review 1.  Optimisation of treatment by applying programmable rate-controlled drug delivery technology.

Authors:  Yie W Chien; Senshang Lin
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

Review 2.  Drug delivery systems and routes of administration of peptide and protein drugs.

Authors:  L M Sanders
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1990 Apr-Jun       Impact factor: 2.441

3.  Microfabrication of an asymmetric, multi-layered microdevice for controlled release of orally delivered therapeutics.

Authors:  Kristy M Ainslie; Casey M Kraning; Tejal A Desai
Journal:  Lab Chip       Date:  2008-05-16       Impact factor: 6.799

4.  Assessment of blood level with controlled-release dosage forms: effect of the rate constant of elimination of the drug.

Authors:  A Aïnaoui; J M Vergnaud
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1998 Jul-Sep       Impact factor: 2.441

5.  Release of diclofenac sodium from polylactide-co-glycolide 80/20 rods.

Authors:  Petrus Viitanen; Esa Suokas; Pertti Törmälä; Nureddin Ashammakhi
Journal:  J Mater Sci Mater Med       Date:  2006-12       Impact factor: 3.896

Review 6.  Versatility of Particulate Carriers: Development of Pharmacodynamically Optimized Drug-Loaded Microparticles for Treatment of Peritoneal Cancer.

Authors:  Jessie L-S Au; Ze Lu; M Guillaume Wientjes
Journal:  AAPS J       Date:  2015-06-19       Impact factor: 4.009

Review 7.  Intraperitoneal therapy for peritoneal cancer.

Authors:  Ze Lu; Jie Wang; M Guillaume Wientjes; Jessie L-S Au
Journal:  Future Oncol       Date:  2010-10       Impact factor: 3.404

Review 8.  Silicon micro- and nanofabrication for medicine.

Authors:  Daniel Fine; Alessandro Grattoni; Randy Goodall; Shyam S Bansal; Ciro Chiappini; Sharath Hosali; Anne L van de Ven; Srimeenkashi Srinivasan; Xuewu Liu; Biana Godin; Louis Brousseau; Iman K Yazdi; Joseph Fernandez-Moure; Ennio Tasciotti; Hung-Jen Wu; Ye Hu; Steve Klemm; Mauro Ferrari
Journal:  Adv Healthc Mater       Date:  2013-04-15       Impact factor: 9.933

9.  Accelerated degradation of poly(epsilon-caprolactone) by organic amines.

Authors:  W J Lin; D R Flanagan; R J Linhardt
Journal:  Pharm Res       Date:  1994-07       Impact factor: 4.200

10.  Estimation of drug-polymer miscibility and solubility in amorphous solid dispersions using experimentally determined interaction parameters.

Authors:  Patrick J Marsac; Tonglei Li; Lynne S Taylor
Journal:  Pharm Res       Date:  2008-09-09       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.